PROBLEM TO BE SOLVED: To provide an inflammatory bowel disease therapeutic agent that has a strong therapeutic effect and causes less systemic side effects.SOLUTION: Use of a sugar steroid compound obtained by replacing the 21 position of desisobutyryl ciclesonide, an active metabolite of ciclesonide, with an acylated monosaccharide yields an inflammatory bowel disease therapeutic agent that has a strong therapeutic effect and causes less systemic side effects.SELECTED DRAWING: NoneCOPYRIGHT: (C)2016,JPO&INPIT【課題】治療効果が強く、全身性の副作用が少ない炎症性腸疾患治療薬を提供すること。【解決手段】シクレソニドの活性代謝物であるデスイソブチリルシクレソニドの21位をアシル化単糖で置換した糖ステロイド化合物を用いることにより、治療効果が強く、全身性の副作用が少ない炎症性腸疾患治療薬である。【選択図】なし
